Severe acute respiratory syndrome-associated coronavirus IVDs
Access comprehensive regulatory information for Severe acute respiratory syndrome-associated coronavirus IVDs in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Pharma Soul Holdings Pty Ltd, manufactured by Hangzhou Testsea Biotechnology Co Ltd in China. The device registration started on August 19, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Intended to detect the novel coronavirus SARS-CoV-2 that causes COVID-19 from symptomatic individuals at the point of care by trained health professionals (nasopharyngeal and nasal swab samples) and for self-testing by lay persons (nasal samples).